Method for the stabilization of endogenous, physiologically active peptides
US5541116A · kind A · utility
9Cited by
4References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 1, 1993 |
| Grant date | Jul 30, 1996 |
| Priority date | — |
| Expiry date | Oct 1, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/2525
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Method for the stabilisation of endogenous physiologically active peptides in human whole blood, serum and plasma samples before and/or during the determination of the-concentration of these peptides by immunodiagnostic or physical assay methods, in which a stabiliser combination which consists of the protease inhibitors amastatin and leupeptin and ethylenediaminetetraacetic acid (EDTA) or contains the stated compounds is added to the samples.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.